Cargando…
Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184897/ https://www.ncbi.nlm.nih.gov/pubmed/32368087 http://dx.doi.org/10.2147/OTT.S257418 |
Ejemplares similares
-
Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study
por: Huang, Lei, et al.
Publicado: (2012) -
Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern] [Erratum]
Publicado: (2020) -
Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Corrigendum]
Publicado: (2013) -
Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection [Expression of concern]
Publicado: (2020) -
Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
Publicado: (2019)